Glen Eagle Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.03K | Hold |
30
| – | – | ﹤0.01% | 728 |
|
|
2025
Q4 | $6.2K | Hold |
30
| – | – | ﹤0.01% | 750 |
|
|
2025
Q3 | $5.38K | Hold |
30
| – | – | ﹤0.01% | 775 |
|
|
2025
Q2 | $4.84K | Hold |
30
| – | – | ﹤0.01% | 736 |
|
|
2025
Q1 | $5.1K | Hold |
30
| – | – | ﹤0.01% | 726 |
|
|
2024
Q4 | $4.99K | Hold |
30
| – | – | ﹤0.01% | 749 |
|
|
2024
Q3 | $5.16K | Hold |
30
| – | – | ﹤0.01% | 754 |
|
|
2024
Q2 | $4.62K | Hold |
30
| – | – | ﹤0.01% | 764 |
|
|
2024
Q1 | $4.61K | Hold |
30
| – | – | ﹤0.01% | 780 |
|
|
2023
Q4 | $4.74K | Hold |
30
| – | – | ﹤0.01% | 744 |
|
|
2023
Q3 | $4.39K | Hold |
30
| – | – | ﹤0.01% | 748 |
|
|
2023
Q2 | $4.59K | Hold |
30
| – | – | ﹤0.01% | 747 |
|
|
2023
Q1 | $4.65K | Sell |
30
-53
| -64% | -$8.32K | ﹤0.01% | 728 |
|
|
2022
Q4 | $12.8K | Hold |
83
| – | – | ﹤0.01% | 565 |
|
|
2022
Q3 | $11K | Buy |
83
+53
| +177% | +$7.44K | ﹤0.01% | 582 |
|
|
2022
Q2 | $4.07K | Hold |
30
| – | – | ﹤0.01% | 742 |
|
|
2022
Q1 | $4.47K | Hold |
30
| – | – | ﹤0.01% | 728 |
|
|
2021
Q4 | $4.86K | Sell |
30
-225
| -88% | -$36.4K | ﹤0.01% | 716 |
|
|
2021
Q3 | $42.3K | Hold |
255
| – | – | 0.01% | 405 |
|
|
2021
Q2 | $44K | Hold |
255
| – | – | 0.01% | 402 |
|
|
2021
Q1 | $40.9K | Hold |
255
| – | – | 0.01% | 383 |
|
|
2020
Q4 | $42.8K | Hold |
255
| – | – | 0.02% | 352 |
|
|
2020
Q3 | $40.1K | Hold |
255
| – | – | 0.02% | 338 |
|
|
2020
Q2 | $42.8K | Hold |
255
| – | – | 0.02% | 310 |
|
|
2020
Q1 | $33.4K | Hold |
255
| – | – | 0.02% | 318 |
|
|
2019
Q4 | $37.9K | Hold |
255
| – | – | 0.02% | 356 |
|
|
2019
Q3 | $31.6K | Hold |
255
| – | – | 0.02% | 348 |
|
|
2019
Q2 | $35.9K | Hold |
255
| – | – | 0.02% | 312 |
|
|
2019
Q1 | $38.5K | Hold |
255
| – | – | 0.03% | 297 |
|
|
2018
Q4 | $31.7K | Hold |
255
| – | – | 0.03% | 300 |
|
|
2018
Q3 | $40.4K | Hold |
255
| – | – | 0.03% | 287 |
|
|
2018
Q2 | $35.7K | Hold |
255
| – | – | 0.03% | 294 |
|
|
2018
Q1 | $33.9K | Hold |
255
| – | – | 0.03% | 285 |
|
|
2017
Q4 | $31.8K | Sell |
255
-100
| -28% | -$12.4K | 0.03% | 285 |
|
|
2017
Q3 | $44K | Buy |
355
+40
| +13% | +$4.73K | 0.04% | 250 |
|
|
2017
Q2 | $35.9K | Hold |
315
| – | – | 0.03% | 243 |
|
|
2017
Q1 | $33.2K | Hold |
315
| – | – | 0.03% | 242 |
|
|
2016
Q4 | $28.6K | Buy |
+315
| New | +$29.5K | 0.03% | 249 |
|
Other funds holding FBT
BFG
Glen Eagle Advisors's FBT Position: Q1 2026 in Review
Glen Eagle Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 30 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #728.
Glen Eagle Advisors first reported a position in FBT in Q4 2016 and has held it in 38 quarters since. The position peaked at $44K in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Glen Eagle Advisors held 30 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.03K as of Q1 2026.
- Glen Eagle Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #728 holding.
- Glen Eagle Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $44K in Q2 2021.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.